HKSE - Delayed Quote HKD
Keymed Biosciences Inc. (2162.HK)
44.050
+2.300
+(5.51%)
At close: 4:08:41 PM GMT+8
Major Holders
| Breakdown | |
|---|---|
| 32.62% | % of Shares Held by All Insider |
| 30.24% | % of Shares Held by Institutions |
| 44.87% | % of Float Held by Institutions |
| 82 | Number of Institutions Holding Shares |
Top Institutional Holders
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| Vanguard International Stock Index-Total Intl Stock Indx | 1.99M | Oct 31, 2022 | 0.71% | 87,452,067 |
| iShares Core MSCI Emerging Markets ETF | 1.19M | Nov 30, 2022 | 0.42% | 52,353,424 |
| Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index | 506.5k | Oct 31, 2022 | 0.18% | 22,311,324 |
| Avantis Emerging Markets Equity ETF | 203.5k | Dec 31, 2022 | 0.07% | 8,964,174 |
| iShares Core MSCI Total International Stock ETF | 164.5k | Nov 30, 2022 | 0.06% | 7,246,224 |
| SPDR (R) Idx Shares-SPDR (R) Emerging Markets Small Cap ETF | 128k | Sep 30, 2022 | 0.05% | 5,638,399 |
| iShares MSCI China Small Cap ETF | 112.5k | Nov 30, 2022 | 0.04% | 4,955,624 |
| SPDR Portfolio Emerging Markets ETF | 97.5k | Sep 30, 2022 | 0.03% | 4,294,874 |
| SPDR (R) Idx Shares-SPDR (R) S&P (R) China ETF | 60k | Nov 30, 2022 | 0.02% | 2,642,999 |
| Avantis Emerging Markets Value ETF | 53.5k | Dec 31, 2022 | 0.02% | 2,356,674 |
Related Tickers
9969.HK InnoCare Pharma Limited
11.040
-0.36%
AN6.DU AnaptysBio Inc
18.90
-0.53%
2126.HK JW (Cayman) Therapeutics Co. Ltd
1.900
-3.06%
2256.HK Abbisko Cayman Limited
9.590
+1.05%
6855.HK Ascentage Pharma Group International
53.400
+8.65%
9966.HK Alphamab Oncology
8.440
-7.76%
1873.HK VIVA BIOTECH
1.780
-1.11%
9606.HK Duality Biotherapeutics, Inc.
214.800
+10.15%
2171.HK CARsgen Therapeutics Holdings Limited
21.150
-1.17%
9939.HK Kintor Pharmaceutical Limited
1.340
-0.74%